Added to YB: 2024-03-06
Pitch date: 2024-03-06
EVO [bullish]
Evotec SE
-73.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
Market Cap
EUR 612.5M
Pitch Price
EUR 13.03
Price Target
11.30 (+232%)
Dividend
N/A
EV/EBITDA
-11.42
P/E
-3.10
EV/Sales
0.87
Sector
Life Sciences Tools and Services
Category
growth
Show full summary:
Evotec SE's Path to Growth and Valuation Insights
EVO: 80% EBITDA segments, 100% from co-owned. FY30 iPSC €67m EBITDA, 15x = €2.30/sh. Other products €33m EBITDA, 15x = €1.10/sh. Just-Evotec Biologics €288m EBITDA, 17x = €11.30/sh. €11.30 PT.
Read full article (2 min)